Clean Science and Technology IPO: Key Points to Consider

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  
  • Home
  • Views On News
  • Jul 5, 2021 - Clean Science and Technology IPO: Key Points to Consider

Clean Science and Technology IPO: Key Points to Consider

Jul 5, 2021

The IPO market is gearing up for a busy season this month with Rs 240 bn worth of IPOs ready to hit the street.

The companies likely to come out with their offers this month include Zomato, Chemplast Sanmar, Vijaya Diagnostic, Glenmark Life, Utkarsh SFB, Shriram Properties, G R Infraprojects, Clean Sciences, Rolex Rings, Seven Islands Shipping, Tatva Chintan among others.

From the above, Clean Science's IPO will open this week on 7 July.

Here are the key details about this IPO...

Issue period: 7 July 2021 to 9 July 2021

IPO Size: Rs 15.5 bn

Price band: Rs 880 to Rs 900 per equity share

Bid lot: 16 shares and in multiples thereof

Face value: Rs 1 per equity share

Object of the issue: The object of the issue is to make an offer for sale (OFS) of equity shares worth Rs 15.5 bn and to achieve the listing benefits on the BSE and NSE.

--- Advertisement ---
Revealed: A Massive 15x EV Opportunity

We concluded the EV Gold Rush special event yesterday.

And it was a mega success. Thousands of Indians had joined us LIVE.

But for some reason you couldn't make it to the event.

At the event, we revealed our complete research on this massive 15x opportunity in electric vehicles...

Including details of 3 EV stocks that could potentially offer you life-changing gains in the long run.

Click Here to Watch Full Details (Available for a limited time)

Of the total issue size, 50% of the offer or approximately 8.6 m equity shares worth Rs 7.7 bn is reserved for qualified institutional buyers (QIB).

Retail quota is 35% of the total issue while non-institutional investors (NII) can bid for 15% of the entire issue.

Clean Sciences will not receive any funds from the public issue as the IPO is entirely an OFS.

The stock will get listed on exchanges by 19 July.

About the company

Incorporated in 2003, Clean Science and Technology is one of the leading chemical manufacturers globally.

It manufactures functionally critical specialty chemicals such as performance chemicals, pharmaceutical intermediates, and FMCG chemicals.

Product Segments

Product Comprising
Performance chemicals MEHQ, BHA and Ascorbyl Palmitate
Pharma intermediates Guaiacol and DCC
FMCG chemicals 4-MAP and Anisole
Other products Acetic acid, Ortho cresto and Para cresol

The company supplies its products to manufacturers and distributors in India as well as overseas markets i.e. China, Europe, USA, Korea, Taiwan, and Japan.

Bayer AG, Genex Laboratories, Nutriad International NV, SRF, Vinati Organics are a few of its customers.

Clean Science is among the few companies which is focused entirely on developing newer technologies using in-house catalytic processes.

This has enabled it to emerge as the largest manufacturer of certain speciality chemicals globally.

--- Advertisement ---
[Alert] Sell These 3 Stocks Immediately

These 3 stocks are ticking time bombs in your portfolio.

It is very likely that you could be owning these 3 overvalued...

fundamentally weak... ready to crash stocks... in your portfolio today.

Because many stock brokers have painted rosy pictures of these stocks. But the reality is starkly different.

If the market crashes, then these stocks could wipe out your wealth.

You should get rid of these stocks as soon as possible.

Click her for full details of these 3 landmines

The company has two manufacturing facilities, both of which are located at Kurkumbh (Maharashtra).

It has also recently set-up a unit at its third manufacturing facility, adjacent to the existing facilities in Kurkumbh.

The financials

The company made a net profit of Rs 489 m in the financial year 2018. This increased to Rs 976.6 m in the following year and Rs 1.4 bn in the financial year 2020.

For the financial year 2021, the performance chemicals segment contributed 69.2% of the total revenues while the contribution of the pharma intermediates segment stood at 16.2%.

FMCG chemicals accounted for 12.3% of the total revenues during the same period.

Financial Snapshot

(Rs m) FY19 FY20 FY21
Revenues 3,933 4,193 5,124
Revenue Growth - 6.6% 22.2%
Expenses 2,680 2,479 2,708
Net Profit 977 1,396 1,984
Net Profit Margin (%) 24.8% 33.3% 38.7%
Net Worth 2,721 3,421 5,397
Return on Equity (ROE) 278.5% 245.1% 272%
Data Source: Company's Red Herring Prospectus (RHP)

The company's export revenue for all these years has been on an average 70% of the turnover.

It also has a consistent track record of paying dividends. The company has been paying dividends since fiscal 2012.

It has paid dividends at the rate of 750%, 900% and 20% for the past three years.

For more details, check out Clean Science and Technology's RHP.

Instant Updates: Join Our Telegram Channel and Get Instant Updates

Peer comparison

On listing, Clean Sciences Technologies will join peers such as Vinati Organics, Fine Organic Industries, Atul, SRF, Navin Fluorine, and PI Industries.

Comparative Analysis

Company Total Income Net Profit Return on Net Worth (%)
Clean Science and Technology 5,381 1,984 36.8
Vinati Organics 9,801 2,693 17.5
Fine Organic Industries 11,503 1,200 16.5
Atul 38,345 6,560 17.1
SRF 84,545 11,980 17.5
Navin Flourine 12,584 2,580 15.8
PI Industries 47,019 7,380 13.8
Data Source: RHP, Equitymaster
Figures in Rs m and as on 31 March 2021

Impressive grey market premium

Even though the company is yet to open its initial share sale, its shares in the unlisted market are trading at a massive 50% premium.

The grey market is an unofficial platform, wherein trading starts after the announcement of IPO price band till the listing of IPO shares.

Clean Science shares are available at a premium of Rs 450.

The traded price comes to around Rs 1,350, which is 50% higher over the issue price of Rs 900.

Note that this will be the fourth IPO by a speciality chemical company in the past year after Rossari Biotech, Chemcon Speciality Chemicals and Anupam Rasayan.

All three are presently trading significantly higher than their issue prices.

Rossari Biotech is trading at Rs 1,198 compared to its issue price of Rs 425, up 182%.

Chemcon Speciality Chemicals is trading at Rs 507 compared to its issue price of Rs 340, up 49%.

Meanwhile, Anupam Rasayan is up 37% if compared with its issue price of Rs 555.

Given the rising demand for speciality chemicals, the outlook for the sector remains promising.

Indian manufacturers have benefited from a rise in demand from global customers who aim to reduce dependence on China.

The IPO of Clean Science is likely to witness good amount of subscription as market sentiment remains positive.

How Clean Science and Technology performs on listing day remains to be seen.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...

Equitymaster requests your view! Post a comment on "Clean Science and Technology IPO: Key Points to Consider". Click here!

1 Responses to "Clean Science and Technology IPO: Key Points to Consider"

Ramesh B

Jul 6, 2021

excellent ! - as usual

Equitymaster requests your view! Post a comment on "Clean Science and Technology IPO: Key Points to Consider". Click here!

More Views on News

GHCL 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GHCL for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GHCL. Also includes updates on the valuation of GHCL.

GALAXY SURFACTANTS 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GALAXY SURFACTANTS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GALAXY SURFACTANTS . Also includes updates on the valuation of GALAXY SURFACTANTS .

RALLIS Announces Quarterly Results (2QFY22); Net Profit Down 31.9% (Quarterly Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

For the quarter ended September 2021, RALLIS has posted a net profit of Rs 564 m (down 31.9% YoY). Sales on the other hand came in at Rs 7 bn (up 0.4% YoY). Read on for a complete analysis of RALLIS's quarterly results.

Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)

Sep 14, 2021

Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?

Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)

Aug 24, 2021

The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.

More Views on News

Most Popular

A Complete Guide for Beginners on How to Invest in IPOs

As an investor, you must have endeavoured to find a suitable opportunity for investing in IPOs. But do you know what is an IP...

Tata Group Stocks are on Fire: Which one Should You Buy? (Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

India's Big PSU Selloff: Watch Out for these Top Stocks (Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

Up 31,500% in a Year! This Packaging Company Sheds its Penny Stock Status (Views On News)

Oct 18, 2021

What's driving the relentless rally in this packaging company?

Insider Alert! Promoters are Increasing their Stakes in these 5 Companies (Views On News)

Oct 19, 2021

Promoters of many small and mid-cap companies are raising their stakes since the last few quarters.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms